Home / Organizations / AstraZeneca


AstraZeneca is one of only a handful of pure-play biopharmaceutical companies which is headquartered in London, United Kingdom. It is the world’s seventh-largest pharmaceutical company measured by 2012 prescription drug sales and has operations in over 100 countries. The company was founded in 1999 through the merger of the Sweden-based Astra AB and the UK-based Zeneca Group (itself formed by the demerger of the pharmaceutical operations of Imperial Chemical Industries in 1993). They employ around 57,500 people worldwide: 32.7% in Europe, 23.5% in North America, 6.1% in Central and South America, 4.2% in the Middle East and Africa and 33.5% in Asia Pacific.

Their primary focus is on three important areas of healthcare: Cardiovascular and Metabolic disease (CVMD); Oncology; and Respiratory, Inflammation and Autoimmunity (RIA). They are also active in the Infection, Neuroscience and Gastrointestinal (ING) disease areas.THey are one of few companies to span the entire life-cycle of a medicine from research and development to manufacturing and supply, and the global commercialisation of primary care and speciality care medicines.

Product Portfolio:

  • Accolate
  • Axanum
  • Brilinta
  • Cubicin
  • EMLA
  • Naropin
  • Onglyza
  • Symlin
  • Vimovo
  • Unimax and many more

Company Information

Type Public Limited Company
Traded as LSE: AZN
Industry Pharmaceutical, Biotechnology
Founded 6 April 1999
Founder NA
Headquarters London, United Kingdom
Key people Leif Johansson (Chairman)
Pascal Soriot (CEO)
Products Pharmaceutical products
Revenue US$26.095 billion (2014)
Net income US$1.235 billion (2014)
Number of employees 50,000 (2014)
Subsidiaries MedImmune
Website www.astrazeneca.com

Check Also

Valeant Pharmaceuticals

Valeant Pharmaceuticals is a publicly traded pharmaceutical company based in Montreal, Canada. The company has …